|
2023 Journal Article Mpox diagnostics: review of current and emerging technologiesLim, Chuan Kok, Roberts, Jason, Moso, Michael, Liew, Kwee Chin, Taouk, Mona L., Williams, Eloise, Tran, Thomas, Steinig, Eike, Caly, Leon and Williamson, Deborah Ann (2023). Mpox diagnostics: review of current and emerging technologies. Journal of Medical Virology, 95 (1) e28429, 1-10. doi: 10.1002/jmv.28429 |
|
2023 Journal Article Antimicrobial exposures in critically ill patients receiving extracorporeal membrane oxygenationShekar, Kiran, Abdul-Aziz, Mohd H, Cheng, Vesa, Burrows, Fay, Buscher, Hergen, Cho, Young-Jae, Corley, Amanda, Diehl, Arne, Gilder, Eileen, Jakob, Stephan M, Kim, Hyung-Sook, Levkovich, Bianca J, Lim, Sung Yoon, McGuinness, Shay, Parke, Rachael, Pellegrino, Vincent, Que, Yok-Ai, Reynolds, Claire, Rudham, Sam, Wallis, Steven C, Welch, Susan A, Zacharias, David, Fraser, John F. and Roberts, Jason A (2023). Antimicrobial exposures in critically ill patients receiving extracorporeal membrane oxygenation. American Journal of Respiratory and Critical Care Medicine, 207 (6), 704-720. doi: 10.1164/rccm.202207-1393oc |
|
2022 Journal Article Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approachesSelby, Philip R., Warner, Morgyn S., Peake, Sandra L., Bardy, Peter, Hiwase, Devendra, Singhal, Deepak, Beligaswatte, Ashanka, Hahn, Uwe, Roberts, Jason A., Yeung, David and Shakib, Sepehr (2022). Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches. Transplant Infectious Disease, 24 (6) e13988, 1-11. doi: 10.1111/tid.13988 |
|
2022 Journal Article Current and emerging treatment options for multidrug resistant Escherichia coli urosepsis: a reviewWalker, Mikaela M., Roberts, Jason A., Rogers, Benjamin A., Harris, Patrick N. A. and Sime, Fekade B. (2022). Current and emerging treatment options for multidrug resistant Escherichia coli urosepsis: a review. Antibiotics, 11 (12) 1821, 1-20. doi: 10.3390/antibiotics11121821 |
|
2022 Journal Article Anticoagulation strategies in non–critically ill patients with Covid-19McQuilten, Zoe K., Venkatesh, Balasubramanian, Jha, Vivekanand, Roberts, Jason, Morpeth, Susan C., Totterdell, James A., McPhee, Grace M., Abraham, John, Bam, Niraj, Bandara, Methma, Bangi, Ashpak K., Barina, Lauren A., Basnet, Bhupendra K., Bhally, Hasan, Bhusal, Khema R., Bogati, Umesh, Bowen, Asha C., Burke, Andrew J., Christopher, Devasahayam J., Chunilal, Sanjeev D., Cochrane, Belinda, Curnow, Jennifer L., Das, Santa Kumar, Dhungana, Ashesh, Di Tanna, Gian Luca, Dotel, Ravindra, DSouza, Hyjel, Dummer, Jack, Dutta, Sourabh ... Tong, Steven Y.C. (2022). Anticoagulation strategies in non–critically ill patients with Covid-19. NEJM Evidence, 2 (2), EVIDoa2200293. doi: 10.1056/evidoa2200293 |
|
2022 Journal Article Reply to Fillatre, et al. and Li, et alAbdul-Aziz, Mohd H., Roberts, Jason A. and Shekar, Kiran (2022). Reply to Fillatre, et al. and Li, et al. American Journal of Respiratory and Critical Care Medicine, 207 (7), 952-953. doi: 10.1164/rccm.202211-2140LE |
|
2022 Journal Article The Staphylococcus aureus Network Adaptive Platform trial protocol: new tools for an old foeTong, Steven Y. C., Mora, Jocelyn, Bowen, Asha C., Cheng, Matthew P., Daneman, Nick, Goodman, Anna L., Heriot, George S., Lee, Todd C., Lewis, Roger J., Lye, David C., Mahar, Robert K., Marsh, Julie, McGlothlin, Anna, McQuilten, Zoe, Morpeth, Susan C., Paterson, David L., Price, David J., Roberts, Jason A., Robinson, J Owen, van Hal, Sebastiaan J., Walls, Genevieve, Webb, Steve A., Whiteway, Lyn, Yahav, Dafna and Davis, Joshua S. (2022). The Staphylococcus aureus Network Adaptive Platform trial protocol: new tools for an old foe. Clinical Infectious Diseases, 75 (11), 2027-2034. doi: 10.1093/cid/ciac476 |
|
2022 Journal Article ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trialDenholm, Justin T., Venkatesh, Balasubramanian, Davis, Joshua, Bowen, Asha C., Hammond, Naomi E., Jha, Vivekanand, McPhee, Grace, McQuilten, Zoe, O’Sullivan, Matthew V. N., Paterson, David, Price, David, Rees, Megan, Roberts, Jason, Jones, Mark, Totterdell, James, Snelling, Thomas, Trask, Nanette, Morpeth, Susan, Tong, Steven YC and on behalf of the ASCOT ADAPT investigators (2022). ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial. Trials, 23 (1) 1014, 1014. doi: 10.1186/s13063-022-06929-y |
|
2022 Journal Article Fred J Boyd Oration 2021Roberts, Jason A. (2022). Fred J Boyd Oration 2021. Journal of Pharmacy Practice and Research, 52 (6), 482-484. doi: 10.1002/jppr.1851 |
|
2022 Journal Article Scoping review on diagnostic criteria and investigative approach in sepsis of unknown origin in critically ill patientsLing, Lowell, Mui, Oliver Oi Yat, Laupland, Kevin B., Lefrant, Jean-Yves, Roberts, Jason A., Gopalan, Pragasan Dean, Lipman, Jeffrey, Joynt, Gavin M., Stelfox, Tom, Niven, Daniel, Paramalingam, Rameiya, Vonderhaar, Derek, Freebairn, Ross, Ling, Lowell, Leung, Patricia, Gopalan, Dean, Lefrant, Jean Yves, Lloret, Sophie, Elotmani, Loubna, Fourie, Cheryl, Saba, Renee, Carlisle, Dougal and Edwards, Felicity (2022). Scoping review on diagnostic criteria and investigative approach in sepsis of unknown origin in critically ill patients. Journal of Intensive Care, 10 (1) 44, 1-10. doi: 10.1186/s40560-022-00633-4 |
|
2022 Journal Article Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 TrialLegg, Amy, Meagher, Niamh, Johnson, Sandra A., Roberts, Matthew A., Cass, Alan, Scheetz, Marc H., Davies, Jane, Roberts, Jason A., Davis, Joshua S. and Tong, Steven Y. C. (2022). Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial. Clinical Drug Investigation, 43 (1), 35-35. doi: 10.1007/s40261-022-01224-9 |
|
2022 Journal Article Optimisation of treatments for oral Neisseria gonorrhoeae infection: Pharmacokinetics Study (STI-PK project) - study protocol for non-randomised clinical trialKong, Fabian Y. S., Unemo, Magnus, Lim, Shueh H., Latch, Ngaire, Williamson, Deborah A., Roberts, Jason A., Wallis, Steven C., Parker, Suzanne L., Landersdorfer, Cornelia B., Yap, Tami, Fairley, Christopher K., Chow, Eric P F, Lewis, David A., Hammoud, Mohamed A. and Hocking, Jane S. (2022). Optimisation of treatments for oral Neisseria gonorrhoeae infection: Pharmacokinetics Study (STI-PK project) - study protocol for non-randomised clinical trial. BMJ open, 12 (11) e064782, 1-8. doi: 10.1136/bmjopen-2022-064782 |
|
2022 Journal Article Evaluation of fosfomycin-sulbactam combination therapy against carbapenem-resistant Acinetobacter baumannii isolates in a hollow-fibre infection modelMohd Sazlly Lim, Sazlyna, Heffernan, Aaron, Naicker, Saiyuri, Wallis, Steven, Roberts, Jason A. and Sime, Fekade Bruck (2022). Evaluation of fosfomycin-sulbactam combination therapy against carbapenem-resistant Acinetobacter baumannii isolates in a hollow-fibre infection model. Antibiotics, 11 (11) 1578, 1-11. doi: 10.3390/antibiotics11111578 |
|
2022 Journal Article Closed-loop control of continuous piperacillin delivery: an in silico studyHerrero, Pau, Wilson, Richard C., Armiger, Ryan, Roberts, Jason A., Holmes, Alison, Georgiou, Pantelis and Rawson, Timothy M. (2022). Closed-loop control of continuous piperacillin delivery: an in silico study. Frontiers in Bioengineering and Biotechnology, 10 1015389, 1-10. doi: 10.3389/fbioe.2022.1015389 |
|
2022 Journal Article Risk factors for nephrotoxicity in methicillin-resistant Staphylococcus aureus bacteraemia: a post hoc analysis of the CAMERA2 trialLegg, Amy, Meagher, Niamh, Johnson, Sandra A., Roberts, Matthew A., Cass, Alan, Scheetz, Marc H., Davies, Jane, Roberts, Jason A., Davis, Joshua S. and Tong, Steven Y. C. (2022). Risk factors for nephrotoxicity in methicillin-resistant Staphylococcus aureus bacteraemia: a post hoc analysis of the CAMERA2 trial. Clinical Drug Investigation, 43 (1), 23-33. doi: 10.1007/s40261-022-01204-z |
|
2022 Journal Article Optimizing meropenem in highly resistant Klebsiella pneumoniae environments: population pharmacokinetics and dosing simulations in critically ill patientsTruong, Anh Quan, Dao, Xuan Co, Vu, Dinh Hoa, Nguyen, Hoang Anh, Do, Thi Hong Gam, Tran, Nhan Thang, Tran, Nhat Minh, Vu, Ngan Binh, Pham, Hong Nhung, Bui, Van Cuong, Trinh, The Anh, Dang, Quoc Tuan, Nguyen, Gia Binh, Lipman, Jeffrey, Cotta, Menino O. and Roberts, Jason A. (2022). Optimizing meropenem in highly resistant Klebsiella pneumoniae environments: population pharmacokinetics and dosing simulations in critically ill patients. Antimicrobial Agents and Chemotherapy, 66 (11) e0032122, 1-11. doi: 10.1128/aac.00321-22 |
|
2022 Journal Article A lipoglycopeptide antibiotic for Gram-positive biofilm-related infectionsBlaskovich, Mark A.T., Hansford, Karl A., Butler, Mark S., Ramu, Soumya, Kavanagh, Angela M., Jarrad, Angie M., Prasetyoputri, Anggia, Pitt, Miranda E., Huang, Johnny X., Lindahl, Fredrik, Ziora, Zyta M., Bradford, Tanya, Muldoon, Craig, Rajaratnam, Premraj, Pelingon, Ruby, Edwards, David J., Zhang, Bing, Amado, Maite, Elliott, Alysha G., Zuegg, Johannes, Coin, Lachlan, Woischnig, Anne-Kathrin, Khanna, Nina, Breidenstein, Elena, Stincone, Anna, Mason, Clive, Khan, Nawaz, Cho, Hye-Kyung, Karau, Melissa J. ... Cooper, Matthew A. (2022). A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science Translational Medicine, 14 (662) abj2381, 1-16. doi: 10.1126/scitranslmed.abj2381 |
|
2022 Journal Article A lipoglycopeptide antibiotic for Gram-positive biofilm-related infectionsBlaskovich, Mark A.T., Hansford, Karl A., Butler, Mark S., Ramu, Soumya, Kavanagh, Angela M., Jarrad, Angie M., Prasetyoputri, Anggia, Pitt, Miranda E., Huang, Johnny X., Lindahl, Fredrik, Ziora, Zyta M., Bradford, Tanya, Muldoon, Craig, Rajaratnam, Premraj, Pelingon, Ruby, Edwards, David J., Zhang, Bing, Amado, Maite, Elliott, Alysha G., Zuegg, Johannes, Coin, Lachlan, Woischnig, Anne-Kathrin, Khanna, Nina, Breidenstein, Elena, Stincone, Anna, Mason, Clive, Khan, Nawaz, Cho, Hye-Kyung, Karau, Melissa J. ... Cooper, Matthew A. (2022). A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science Translational Medicine, 14 (662) abj2381. doi: 10.1126/scitranslmed.abj238 |
|
2022 Journal Article Precision dosing software to optimize antimicrobial dosing: a systematic search and follow-up survey of available programsJager, Nynke G. L., Chai, Ming G., van Hest, Reiner M., Lipman, Jeffrey, Roberts, Jason A. and Cotta, Menino O. (2022). Precision dosing software to optimize antimicrobial dosing: a systematic search and follow-up survey of available programs. Clinical Microbiology and Infection, 28 (9) 1211, 1211-1224. doi: 10.1016/j.cmi.2022.03.041 |
|
2022 Journal Article Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: a structured, narrative reviewHernández-Mitre, María Patricia, Tong, Steven Y. C., Denholm, Justin T., Dore, Gregory J., Bowen, Asha C., Lewin, Sharon R., Venkatesh, Balasubramanian, Hills, Thomas E., McQuilten, Zoe, Paterson, David L., Morpeth, Susan C. and Roberts, Jason A. (2022). Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: a structured, narrative review. Clinical Pharmacokinetics, 61 (10), 1331-1343. doi: 10.1007/s40262-022-01170-x |
